These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6192496)

  • 1. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta 2-microglobulin in lymphoproliferative disorders].
    Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
    G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta 2 microglobulin in some hematologic neoplasms].
    Rodríguez MA; Lira P; Foradori A; Grebe G
    Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
    Child JA; Kushwaha MR
    Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial measurement of beta2 microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Cooper EH; Bunning R; Illingworth S; Späti B; Child JA
    Biomedicine; 1978 Jul; 29(5):154-8. PubMed ID: 82455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta 2 microglobulin in lymphoproliferative status].
    Schaimberg L; Ikeda F; Cordeiro M; Santos RA; Murakami S; Scheinberg MA
    Rev Paul Med; 1987; 105(3):183-4. PubMed ID: 3329760
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of biologic tests in malignant hemopathies].
    Clément F
    Schweiz Med Wochenschr; 1983 Jul; 113(26):948-51. PubMed ID: 6612275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neopterin levels in haematological malignancies.
    Caenazzo A; Pietrogrande F; Sgarabotto D; Dazzi F; Sartori D; Vattamattathil KP; Girolami A
    Haematologica; 1993; 78(4):225-9. PubMed ID: 8294054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta 2 microglobulin in lymphoproliferative disorder.
    Spati B; Cooper EH; Child JA
    Lancet; 1978 Oct; 2(8095):897-8. PubMed ID: 81446
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
    Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
    Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta2-Microglobulin in lymphoproliferative disorders with special reference to gammapathies.
    Cassuto JP; Krebs BP; Joyner MV; Viot G; Dujardin P; Audoly P; Masseyeff R
    Pathol Biol (Paris); 1978 Sep; 26(6):345-7. PubMed ID: 83580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
    Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
    Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.